MultiplexDX International Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • MultiplexDX International's estimated annual revenue is currently $6.8M per year.(i)
  • MultiplexDX International's estimated revenue per employee is $155,000

Employee Data

  • MultiplexDX International has 44 Employees.(i)
  • MultiplexDX International grew their employee count by -8% last year.

MultiplexDX International's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M2-60%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M160%N/AN/A
#8
$7.4M480%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is MultiplexDX International?

MultiplexDX is an international corporation established in 2015 consisting of two units: MultiplexDX Inc. located in Maryland U.S.A. and MultiplexDX s.r.o. located in Slovakia. Our main goal is to eliminate cancer misdiagnosis by launching 98% accurate, quantitative and accessible diagnostic tests. We also operate a boutique oligohouse offering highly specialized custom oligonucleotides to the research community. The primary objectives of the company are: i) development of the technologies and the products for molecular diagnostic markets superior to currently available products; ii) core facility service using proprietary Multiplex TM technology iii) development of hi-tech 3D digital pathology services. Find out more about MultiplexDX on our official website and in social media: http://www.multiplexdx.com/ https://www.facebook.com/multiplexdx/ https://twitter.com/@multiplexdx http://bit.ly/MDXGooglePlus https://www.youtube.com/c/multiplexdx

keywords:N/A

N/A

Total Funding

44

Number of Employees

$6.8M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.2M44-4%N/A
#2
$3.6M442%N/A
#3
$5.1M447%N/A
#4
$10.8M44-20%N/A
#5
$3.5M4429%N/A